Day One Biopharmaceuticals, Inc.
DAWN
$21.31
$0.020.09%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 441.11M | 451.58M | 453.10M | 473.02M | 531.72M |
| Total Receivables | 26.74M | 16.70M | 19.67M | 18.05M | 13.88M |
| Inventory | 6.33M | 7.06M | 6.54M | 3.57M | 3.32M |
| Prepaid Expenses | 4.46M | 4.82M | 5.59M | 4.28M | 5.20M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 6.46M | 9.82M | 9.52M | 9.73M | 8.22M |
| Total Current Assets | 485.10M | 489.97M | 494.43M | 508.65M | 562.33M |
|
|
|||||
| Total Current Assets | 485.10M | 489.97M | 494.43M | 508.65M | 562.33M |
| Net Property, Plant & Equipment | 4.48M | 4.68M | 4.82M | 5.09M | 4.71M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 18.02M | 18.82M | 19.61M | 20.41M | 15.63M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 230.00K | 317.00K | 183.00K | 215.00K | 121.00K |
| Total Assets | 507.83M | 513.78M | 519.04M | 534.36M | 582.79M |
|
|
|||||
| Total Accounts Payable | 3.73M | 5.78M | 5.09M | 2.54M | 3.26M |
| Total Accrued Expenses | 54.62M | 48.21M | 44.13M | 40.58M | 68.63M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 174.00K | 161.00K | 153.00K | 62.00K | 10.00K |
| Total Finance Division Other Current Liabilities | 2.00M | 2.32M | 1.85M | 4.70M | 1.55M |
| Total Other Current Liabilities | 2.00M | 2.32M | 1.85M | 4.70M | 1.55M |
| Total Current Liabilities | 60.52M | 56.47M | 51.22M | 47.88M | 73.45M |
|
|
|||||
| Total Current Liabilities | 60.52M | 56.47M | 51.22M | 47.88M | 73.45M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.62M | 2.73M | 2.85M | 2.85M | 2.59M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.52M | 3.71M | 4.13M | 4.11M | 3.99M |
| Total Liabilities | 66.67M | 62.91M | 58.20M | 54.84M | 80.04M |
|
|
|||||
| Common Stock & APIC | 1.10B | 1.09B | 1.08B | 1.07B | 1.06B |
| Retained Earnings | -661.40M | -640.13M | -620.40M | -590.08M | -554.08M |
| Treasury Stock & Other | 65.00K | 69.00K | -92.00K | -52.00K | 84.00K |
| Total Common Equity | 441.16M | 450.87M | 460.83M | 479.51M | 502.75M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 441.16M | 450.87M | 460.83M | 479.51M | 502.75M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 441.16M | 450.87M | 460.83M | 479.51M | 502.75M |
|
|
|||||